Month: January 2013
Analysis: Entering the age of the $1 million medicine
LONDON (Reuters) – The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the price. The gene therapy for lipoprotein lipase deficiency (LPLD), a hereditary disorder that raises the risk of potentially lethal inflammation of the pancreas, is likely to cost more than $1 million per patient when it goes on sale in Europe this summer. Rare or so-called orphan diseases are winning unprecedented attention from drug developers. …
Abbott wins FDA approval for heart stent
(Reuters) – Abbott Laboratories’ Xience Xpedition heart stent was approved by U.S. health regulators and will be launched in the United States immediately, the company said on Thursday. Heart stents are tiny tubular devices that prop open diseased blood vessels after angioplasty. Abbott’s stent delivers a drug, everolimus, which helps keep the vessel from reclogging. Abbott competes with Medtronic Inc and Boston Scientific in the market for heart stents. (Reporting By Debra Sherman; editing by John Wallace)
Extreme Weight Loss: Pair Drops Hundreds of Pounds
At age 33, Missy Hendricks has spent her entire lifetime at war with her weight. “My maiden name was Blinkenship and they’d call me ‘Battle Ship’ and that just stuck in my head,” Hendricks told ABC News. By the age of 20, Hendricks weighed nearly…
Russia: Navy Embarks on Major Exercise
Russian warships have embarked on a long voyage to the Black and Mediterranean Seas to take part in what the Defense Ministry said Wednesday would be the largest naval exercise in decades. It said the exercise would test the ships' ability to act …
See all stories on this topic »
Watch: Infant in Womb Shown Holding Doctor’s Hand
Bayer’s Nexavar meets goal in thyroid cancer trial
FRANKFURT (Reuters) – German drugmaker Bayer said its cancer treatment Nexavar reached a goal of improving the survival of patients with a certain type of thyroid cancer in a late-stage clinical trial. The company said on Thursday it planned to submit data from the trial in the coming months in a bid to win regulatory approval to sell Nexavar as a treatment for radioactive iodine (RAI) refractory differentiated thyroid cancer. It would present a detailed analysis of the study, in which 417 patients took part, at an upcoming medical meeting, it added, without providing details. …
Obese People on Benefits Targeted in Forced Exercise Plan
Flu? Malaria? Disease forecasters look to the sky
NEW YORK (AP) — Only a 10 percent chance of showers today, but a 70 percent chance of flu next month.
Get Fit for 2013: Trainer Harley Pasternak Answers ‘GMA’ Viewers’ Questions
It’s a new year and many people have made resolutions to get fit. Celebrity trainer Harley Pasternak (@harleypasternak) has trained celebrities including Rihanna and Katy Perry and this morning he appeared on “Good Morning America” to show specific exercise moves to get you an all-star…
Keeping Fit and Having Fun as We Age
Regular physical activity at any age can help you live longer, feel better and reduce health problems. But far too many people, including baby boomers, don't get the exercise they need. According to the …
Consumer Reports Puts Exercise Equipment To The Test
| PITTSBURGH (KDKA) – If getting into shape is high on your list of New Year's resolutions and you're wondering if exercise devices can help get you there faster, you're in luck. Consumer Reports just put a bunch of them to the test. First they started … See all stories on this topic » |
 CBS Local |